Global Longlife Hospital and Research Ltd.

42.75 +1.25 ▲3.0%

11 December 2023, 04:01:00 PM
Volume: 2,000

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.globalhospital.co.in
Market Cap 44.89 Cr.
Enterprise Value(EV) 56.19 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.74 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 24.56 Trailing Twelve Months Ending 2023-03
Industry PE 63.18 Trailing Twelve Months Ending 2023-03
Book Value / Share 58.94 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.73 Calculated using Price: 42.75
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.05 Cr. 10,500,000 Shares
FaceValue 10
About Global Longlife Hospital and Research Ltd.
The company provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services. Global Longlife Hospital is certified by the National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited).

Global Longlife Hospital and Research Ltd. Delivery

Delivered Qty
Traded Qty

Global Longlife Hospital and Research Ltd. Performance

1 Day
+3.01%
1 Week
-2.73%
1 Month
-0.58%
3 Month
-8.06%
6 Month
-0.58%
1 Year
-32.73%
2 Year
5 Year
10 Year

Global Longlife Hospital and Research Ltd. Fundamental Ratios

5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 11.05 -7.23 18.94 29.65 4.82
Return on Capital Employed (%) 12.09 3.69 13.49 29.36 6.69
Return on Assets (%) 3.40 -2.19 5.72 11.10 3.47

Global Longlife Hospital and Research Ltd. Balance Sheet

Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 12 11 14 17 64 65
Non Curr. Liab. 15 14 9 1 2 0
Curr. Liab. 13 13 10 14 8 12
Minority Int.
Equity & Liab. 40 39 33 31 74 77
Non Curr. Assets 25 23 18 17 38 40
Curr. Assets 15 16 12 11 34 37
Misc. Exp. not W/O 4 3 2
Total Assets 40 39 33 31 74 77

Global Longlife Hospital and Research Ltd. Profit and Loss

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 35 34 33 33 24
Other Income 0 0 0 0 0
Total Income 35 34 33 33 24
Total Expenditure -28 -30 -27 -25 -19
PBIDT 7 4 6 8 4
Interest -2 -2 -2 -2 0
Depreciation -2 -2 -1 -1 -1
Taxation -1 0 0 -2 -1
Exceptional Items
PAT 1 -1 2 4 2
Adjusted EPS 3 5 2

Global Longlife Hospital and Research Ltd. Cash Flow

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 4 7 9 -40
Cash Fr. Inv. 0 0 0 0 -2
Cash Fr. Finan. -5 -3 -7 -10 46
Net Change 0 1 0 0 3
Cash & Cash Eqvt 0 1 0 0 4

Global Longlife Hospital and Research Ltd. Shareholding Pattern

6 Qtrs 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 54.29 54.29 54.29 54.29 54.29 54.29
Public 45.71 45.71 45.71 45.71 45.71 45.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Global Longlife Hospital and Research Ltd. Announcements

Sat, 11 Nov 2023
Unaudited Financial Results For The Half Year Ended On September 30 2023
Unaudited Financial Results for the Half Year ended on September 30 2023.
Sat, 11 Nov 2023
Board Meeting Outcome for For Unaudited Financial Results For The Half Year Ended On September 30 2023
Board Meeting Outcome for approval of Unaudited Financial Results for the Half Year ended on September 30 2023
Sat, 04 Nov 2023
Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30 2023
Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve the Unaudited Financial Results along with the Limited Review Report for the Half year ended on September 30 2023 and other matters.

Global Longlife Hospital and Research Ltd. Technical Scans

Mon, 11 Dec 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
High Decrease in 1 Year High Decrease in 1 Year
Closing Near 100 SMA Closing Near 100 SMA

Global Longlife Hospital and Research Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,829.45 1,235.70 +0.0%
Divi's Laboratories Ltd. 97,460.15 3,668.25 -0.4%
Cipla Ltd. 97,091.96 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. 91,293.11 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,752.32 5,544.70 -0.1%
Mankind Pharma Ltd. 76,862.91 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 70,347.58 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 73.18 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 28.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 17.93 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.34 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 59.96 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.73 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.98 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.69 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 3.91 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.58 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.12 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Global Longlife Hospital and Research Ltd. FAQ's

What is Global Longlife Hosp share price?

Can I buy Global Longlife Hosp shares now?

What is the Market Cap of Global Longlife Hosp?

What are the key metrics to analyse Global Longlife Hosp?

What is the 52 Week High and Low of Global Longlife Hosp?

What is the trend of Global Longlife Hosp share price?